Bristol Myers Squibb
Verified account Aggregated content
VP and Head of Global Market Access, Cell Therapy Phung Osborn is a true leader working to increase patient access to cell therapies. A long-time advocate focused on overcoming barriers to care, we’re thrilled to celebrate Phung as our BMS @PhRMA 2026 #WorkingforCures Champion. -
Our Chairman and CEO Chris Boerner rang the @NYSE #ClosingBell alongside colleagues, underscoring our shared commitment to discovering, developing and delivering medicines that address serious diseases and improve patients’ lives around the world. #OneBMS https://t.co/peR2ZtkhM9 -
#MEDIA: The @US_FDA approved our treatment for active psoriatic arthritis (PsA), bringing a new option for adults living with the condition. Learn more: https://t.co/xj3gVXxV11 https://t.co/cCLg8WOd8k -
#MEDIA: Announcing positive topline results from a Phase 3 trial evaluating our investigational CELMoD agent for adult patients with relapsed or refractory #MultipleMyeloma. https://t.co/6g55GwOGDk https://t.co/eP0UrHuSFW -
